Medicines Act 1968, Paragraph 17 is up to date with all changes known to be in force on or before 01 March 2025. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
17U.K.Any such arrangements as are mentioned in paragraph 15(b) or paragraph 16 of this Schedule,—
F1(a). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(b)if F2... they are made by an enforcement authority in England and Wales other than [F3the Secretary of State], shall be arrangements approved by [F3the Secretary of State];
(c)if they are made by an enforcement authority in Scotland other than the Secretary of State, shall be arrangements approved by the Secretary of State;
and any such arrangements as are mentioned in paragraph 15(b) of this Schedule, if made by [F4the Pharmaceutical Society of Northern Ireland] in Northern Ireland, shall be arrangements approved by [F5the Minister for Health, Social Services and Public Safety].
Textual Amendments
F1Sch. 3 para. 17(a) omitted (1.10.2006) by virtue of The Veterinary Medicines Regulations 2006 (S.I. 2006/2407), reg. 1, Sch. 8 para. 68(a) (with regs. 2(4), 3)
F2Words in Sch. 3 para. 17(b) omitted (1.10.2006) by virtue of The Veterinary Medicines Regulations 2006 (S.I. 2006/2407), reg. 1, Sch. 8 para. 68(b) (with regs. 2(4), 3)
F3Words substituted by virtue of S.I. 1968/1699, arts. 2, 5(4)(a)
F4Words in Sch. 3 para. 17 substituted (14.8.2012) by virtue of The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 34(d)(i) (with Sch. 32)
F5Words in Sch. 3 para. 17 substituted (14.8.2012) by The Human Medicines Regulations 2012 (S.I. 2012/1916), reg. 1(2), Sch. 34 para. 34(d)(ii) (with Sch. 32)
Modifications etc. (not altering text)
C1Functions of Secretary of State in matters only affecting Wales exercisable by Secretary of State for Wales: S.I. 1969/388, art. 2(1)
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
